[1] GOBBI P G,BERGONZI M,COMELLY M,et al.The prognostic role of time to diagnosis and presenting symptoms in patients with pancreatic cancer[J].Cancer Epidemiol,2013,37(2):186-190.
[2] KOONTONGKAEW S.The tumor microenvironment contribution to development,growth,invasion and metastasis of head and neck squamous cell carcinomas[J].J Cancer,2013,4(1):66-83.
[3] SHARON Y,ALON L,GLANZ S,et al.Isolation of normal and cancer-associated fibroblasts from fresh tissues by fluorescence activated cell sorting (FACS)[J].JoVE,2013(71):e4425.
[4] CIRRI P,CHIARUGI P.Cancer-associated-fibroblasts and tumor 图2 胰腺癌间质Cav-1表达阳性和阴性患者生存曲线图 Fig 2 Kaplan-Meier analysis of the overall postoperative survival curves in patients with pancreatic cancer according to immunohistochemical staining as positive or negative of stromal Cav-1 expressioncells:a diabolic liaison driving cancer progression[J].Cancer Metast Rev,2012,31(1-2):195-208.
[5] SONG Y,XUE L L,DU S,et al.Caveolin-1 knockdown is associated with the metastasis and proliferation of human lung cancer cell line NCI-H460[J].Biomed Pharmacother,2012,66(6):439-447.
[6] HA T,HER N,LEE M,et al.Caveolin-1 increases aerobic glycolysis in colorectal cancers by stimulating HMGA1-mediated GLUT3 transcription[J].Cancer Res,2012,72(16):4097-4109.
[7] SIMPKINS S A,HANBY A M,HOLLIDAY D L,et al.Clinical and functional significance of loss of caveolin-1 expression in breast cancer-associated fibroblasts[J].J Pathol,2012,227(4):490-498.
[8] 杨晓寒,熊海,关珠珠,等.Caveolin-1高表达抑制人小细胞肺癌(SCLC)细胞凋亡[J].中国癌症研究,2012,30(6):453-462.
[9] TANG Y,ZENG X T,HE F,et al.Caveolin-1 is related to invasion,survival,and poor prognosis in hepatocellular cancer[J].Med Oncol,2012,29(2):977-984.
[10] ZHENG J.Energy metabolism of cancer:glycolysis versus oxidative phosphorylation(Review)[J].Oncol Lett,2012,4(6):1151-1157.
[11] PAVLIDES S,VERA I,GANDARA R,et al.Warburg meets autophagy:cancer-associated fibroblasts accelerate tumor growth and metastasis via oxidative stress,mitophagy,and aerobic glycolysis[J].Antioxid Redox Signal,2012,16(11):1264-1284.
[12] BONUCCELLI G,WHITAKER-MENEZES D,CASTELLO-CROS R,et al.The reverse warburg effect glycolysis inhibitors prevent the tumor promoting effects of caveolin-1 deficient cancer associated fibroblasts[J].Cell Cycle,2010,9(10):1960-1971.
[13] AYALA G,MORELLO M,FROLOV A,et al.Loss of caveolin-1 in prostate cancer stroma correlates with reduced relapse-free survival and is functionally relevant to tumour progression[J].J Pathol,2013,231(1):77-87.
[14] ZHAO X D,HE Y Y,GAO J,et al.Caveolin-1 expression level in cancer associated fibroblasts predicts outcome in gastric cancer[J].PLoS One,2013,8 (3):e59102.
[15] WU K N,QUEENAN M,BRODY J R,et al.Loss of stromal caveolin-1 expression in malignant melanoma metastases predicts poor survival[J].Cell Cycle,2013,10(24):4250-4255.
[16] TAHIR S A,PARK S,THOMPSON T C.Caveolin-1 regulates VEGF-stimulated angiogenic activities in prostate cancer and endothelial cells[J].Cancer Biol Ther,2009,8(23):2286-2296.
[17] MAO Y,KELLER E T,GARFIELD D H,et al.Stromal cells in tumor microenvironment and breast cancer[J].Cancer Metast Rev,2013,32(2):305-315.
[18] BALKWILL F R,CAPASSO M,HAGEMANN T.The tumor microenvironment at a glance[J].J Cell Sci,2012,125(23):5591-5596.
[19] PAVLIDES S,WHITAKER-MENEZES D,CASTELLO-CROS R,et al.The reverse warburg effect:aerobic glycolysis in cancer associated fibroblasts and the tumor stroma[J].Cell Cycle,2009,8(23):3984-4001.
[20] WITKIEWICZ A K,DASGUPTA A,SAMMONS S,et al.Loss of stromal caveolin-1 expression predicts poor clinical outcome in triple negative and basal-like breast cancers[J].Cancer Biol Ther,2010,10(2):135-143.
[21] WITKIEWICZ A K,NGUYEN K H,DASGUPTA A,et al.Co-expression of fatty acid synthase and caveolin-1 in pancreatic ductal adenocarcinoma:implications for tumor progression and clinical outcome[J].Cell Cycle,2008,7(19):3021-3025.
[22] TRIMMER C,SOTGIA F,WHITAKER-MENEZES D,et al.Caveolin-1 and mitochondrial SOD2 (MnSOD) function as tumor suppressors in the stromal microenvironment a new genetically tractable model for human cancer associated fibroblasts[J].Cancer Biol Ther,2011,11(4):383-394.
[23] PATANI N,MARTIN L,REIS-FILHO J S,et al.The role of caveolin-1 in human breast cancer[J].Breast Cancer Res Tr,2012,131(1):1-15.
[24] PANCOTTI F,RONCUZZI L,MAGGIOLINI M,et al.Caveolin-1 silencing arrests the proliferation of metastatic lung cancer cells through the inhibition of STAT3 signaling[J].Cell Signal,2012,24(7):1390-1397.
[25] SUN M,GUAN Z,LIU S,et al.Caveolin-1 interferes cell growth of lung cancer NCI-H446 cell through the interactions with phosphoERK1/2,estrogen receptor and progestin receptor[J].Biomed Pharmacother,2012,66(4):242-248.
[26] SALANI B,MAFFIOLI S,HAMOUDANE M,et al.Caveolin-1 is essential for metformin inhibitory effect on IGF1 action in non-small-cell lung cancer cells[J].FASEB J,2012,26(2):788-798.
[27] DU X,QIAN X,PAPAGEORGE A,et al.Functional interaction of tumor suppressor dlc1 and caveolin-1 in cancer cells[J].Cancer Res,2012,72(17):4405-4416.
[28] GUMULEC J,SOCHOR J,HLAVNA M,et al.Caveolin-1 as a potential high-risk prostate cancer biomarker[J].Oncol Rep,2012,27(3):831-841.
[29] SOTGIA F,MARTINEZ-OUTSCHOORN U E,HOWELL A,et al.Caveolin-1 and cancer metabolism in the tumor microenvironment:markers,models,and mechanisms[J].Annu Rev Pathol,2012,7:423-467.
[30] 林传彬,张才全,吴帅.Caveolin-1在结肠癌中的表达及其与结肠癌发生发展的关系[J].中国现代医学杂志,2011,21(14):1600-1602. |